Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

By D. Hayes, M. Cristofanilli, G. Budd, M. Ellis, A. Stopeck, M. Miller, J. Matera, W. Allard, G. Doyle, L. Terstappen. Clinical Cancer Research, 2006

1,004 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/16cd2eed9077804c5e807c4e6c9700922771621c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. L. Terstappen
2. K. Pantel
3. G. Doyle
4. M. Miller
5. Ruud H. Brakenhoff
6. B. Brandt
7. C. Alix‐Panabières

In Oncology

1. K. Pantel
2. G. Doyle
3. L. Terstappen
4. M. Miller
5. Ruud H. Brakenhoff
6. B. Brandt
7. C. Alix‐Panabières
8. J. Massagué

In Pulmonary and Respiratory Medicine

1. K. Pantel

Citations in the corpus

• Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer (2009, methodology): “Ideally, these modalities would be noninvasive, be independent of treatment, and provide quantitative real-time analysis of tumor activity in a variety of carcinomas.”
• Detection, clinical relevance and specific biological properties of disseminating tumour cells (2008, background): “The system appears to provide clinically useful information on the prognosis of patients with metastatic breast, colon and prostate cance”